A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Rai, Yogesh Kumar
- A Study of Protective effect of Ginger (Zingiber Officinale) in Normal and Carbon-Tetrachloride Induced Hepatotoxic Rats in Western U.P. India
Authors
1 Department of Medicine, Saraswathi Institute of Medical Sciences Hapur, U.P., IN
2 Department of Pharmacology, Saraswathi Institute of Medical Sciences Hapur, U.P., IN
3 Department of Biochemistry, Saraswathi Institute of Medical Sciences Hapur, U.P., IN
Source
Indian Journal of Forensic Medicine & Toxicology, Vol 7, No 2 (2013), Pagination: 64-67Abstract
The current study has been conducted to investigate the affect of ginger on hepatic antioxidant enzymes system in carbon tetrachloride induced hepatotoxic rats. The first set of animals received only ginger-supplemented diet while the another set were treated with CCl4 before maintaining them on ginger-based diets.Consumption of the experimental diets by the normal rats produced significant elevation (p<0.05) in the activities of the hepatic aspartate aminotransferase and alanine aminotransferase as well as the concentration of protein and albumin. Administration of CCl4 to the second set of rats resulted in the alteration of the liver function parameters . However, the significantly reduced (p<0.05) marker enzymes such as AST, ALT, due to CCl4 treatment were restored towards normalization on consumption of ginger diet. The biochemical parameters like total protein and albumin were also restored towards normal levels. The findings indicate that the ginger is an efficient hepatoprotective and antioxidant agent against CCl4-induced liver toxicity.Keywords
Aminotransferases, Carbon tetrachloride (CCl4), De novo synthesis Hepatotoxicity, SpicesReferences
- KM Nadkarni; AK Nadkarni. In: Indian Materia Medica, 3rd Ed., Popular Prakashan Ltd.,Bombay. 1976
- K Srinivasan. Food Rev.Int. 2005 , 21, 167-188.
- E Langner; S Greifenberg; J Gruenwald. Adv Ther, 1998, 15, 25.
- S Arctangder. In Perfume and Flavour Materials of Natural Origin, Elizabeth Publisher, USA, 1960, pp. 275.
- HK Bakhru. In Herbs That Heal: Natural Remedies for Good Health. Oriental Paper Backs, New Delhi, 1999, pp. 97.
- SA Meyer; AP Kulkarni. In: Introduction to biochemical toxicology. 3rd Ed., John Wiley and Sons, New-York, 2001, pp. 487.
- PL Wolf. Ind. J. Clin. Biochem. 1999, 14, 59-64.
- M Guntupalli; V Chandana; P Pushpangadan; I Annie Shirwaikar. J. Ethnopharmacol. 2006,103, 484–490
- SB Rao; HM Mehendale. Biochem. J. 1989, 262, 721-725
- EO Ngaha. Biochem. Pharmacol., 1982, 3,1843- 1847.
- E Malloy; K Evelyn. J. Biol. Chem. 1937, 119, 481- 485.
- DT Plummer. In An introduction to Practical Biochemistry. 2nd Ed. McGraw- Hill,London, 1978, pp. 144-145
- S Reitman; S Frankel. Am. J. Clin. Pathol., 1957, 28, 56-63
- RF Woodson. (1983). In Probability and Mathematical Statistics. Wiley, Chichester, 1983, pp. 315-316.
- O. Ulican; M Greksak; O Vancova; L Zlatos; S Galbavy; P Bozek; M Nakano. Physiol. Res. 2003, 52, 461-466.
- E Porchezhian; SHAnsari. Phytomed. 2005, 12, 62-64.
- H Wada; EE Snell. J. Biol. Chem. 1962, 237, 133-137.
- RM Wells; RH Mclntyre; AK Morgan; PS Davies. Comp. Biochem. Physiol. 1986, 64A, 565-571.
- MT Yakubu; MA Akanji; IO Salau. Nig. J. Biochem. Mol. Biol., 2001, 16(2): 177-182.
- AK Mujumddar; AS Upadhye; AM Pradhan. Ind. J. Pharm. Sci. 1998, 60, 363.
- AR Opoku; IM Ndlovu; SE Terblanche; AH Hutchings. South Afr. J. Bot. 2007, 73, 372–377.
- Y Aniya; T Koyama; C Miyagi; M Miyahira; C Inomata; S Kinoshita; T Ichiba. Biol. Pharm. Bull. 2005, 28, 19-23.
- Valproate-induced Subclinical Hypothyroidism
Authors
1 Department of Pharmacology, Saraswathi Institute of Medical Sciences Hapur, Ghaziabad, U.P., IN
2 Department of Biochemistry, Saraswathi Institute of Medical Sciences Hapur, Ghaziabad, U.P., IN
3 Department of Obstetrics & Gynecology, Saraswathi Institute of Medical Sciences Hapur, Ghaziabad, U.P., IN
Source
Indian Journal of Forensic Medicine & Toxicology, Vol 5, No 1 (2011), Pagination: 110-112Abstract
Introduction:
Sodium valproate (VPA) is widely used for the treatment of partial and generalized epilepsy in childhood and adolescence. The results of the studies that have evaluated the effect of VPA monotherapy on thyroid function in epileptic patients are controversial.
Objective:
Studies on the effects of sodium valproate on thyroid hormone balance in patients with epilepsy are conflicting. The aim of this study was to prospectively evaluate the changes in thyroid profile in epilepsy treated with valproate monotherapy.
Methods:
Serum level of triiodothyronine (T3), thyroxin (T4) and thyroid stimulating hormone (TSH) were determined in 40 epileptic patients of valproate monotherapy by EIA method.
Results:
Epileptic patients had slightly decreased triiodothyronine (T3) and thyroxin (T4), whereas TSH level was significantly increased on valproate monotherapy.
Conclusion:
The results showed that valproate may induce subclinical hypothyroidism. This suggests a need for careful monitoring of serum TSH level in epileptic patients receiving valproate drug.
Keywords
Antiepileptic Drugs (AEDS), Epilepsy, Thyroid Hormones, Endocrinological System, Subclinical Hypothyroidism, Valproate (VPA).References
- Fichsel H. Effect of anticonvulsant drug on thyroid hormone in epileptic patients. Epilepsia.1978; 19:323- 36.
- Liewendahl K, Majuri H. Thyroid function tests in patients on long term treatment with various anticonvulsant drugs. Clin Endocrinol Oxf, 1978; 8:185-91.
- Larkin JG, Macphee GJ. Thyroid hormone concentrations in epileptic patients. Eur J Clin Pharmacnl, 1989; 36:213- 216.
- Allison G. Some patients on epileptic drugs devlep thyroid abnormalities. American academy of neurology 62nd annual meeting poster PD2.007 Presented April 13, 2010.
- Toone BK, Edeh J. Hormone and behavioral changes in male epileptics. Advances epileptotogy: XV epilepsy international symposium New York: Raven Press 1984; 283- 289.
- Stjermholm MR. Thyroid function test in diphenylhydantoin treated patients. Clin Chem, 1975; 21:1388-1392.
- Isojarvi JIT. Thyroid function with antiepileptic drugs. Epilepsio, 1992; 3:142-148.
- Yuksel A, Kartal A. Serum thyroid hormone and pituitary response to thyrotropin releasing hormone in epileptic patients receiving antiepileptic medications. Ada. Paediatr Jpn, 1993; 35:108-112.
- Ericsson UB. Thyroblobuline and thyroid hormone in patients on long term treatment with anticonvulsant drugs. Epilepsia, 1985; 2:594-600.
- Deda G. Effect of anticonvulsant drugs on thyroid hormone in epileptic children. Turk J Pediatr, 1992; 34:239- 244.
- Sathyanaraynan U. Textbook of Biochemistry. Press book and allied private limited 1st Edition March 1999 revised edition.2001; 238-241.
- Juul-Jensen P. Prevalence of epilepsy. Stor Arhus Ugeskr Laeg, 1975; 137:2380-2388.
- Hauser WA. Epidemiology of epilepsy. Rochester, Minnesota, 1935 through 1967, Epilepsia16; 1-66.
- Reynolds EH. Iatrogenic disorders in epilepsy. In Williams (ed) Modern trends in neurology, Butterworth, London, 1970; 5:271-286.
- Hansen JM. The effect of phenytoin on thyroid hormone. Clin J Endcrinol Melah, 1974; 39:785-789.
- Rootwelt K. effect of anticonvulsant drugs on serum levels on thyroid hormone.Scanuj Clin Lab Invst, 1978; 38:731- 736.
- Alison P. Effect of treatment on endocrine function in patients with epilepsy. Current treatment option in neurology, 2005; 7:4.
- Isojrvi JIT. Serum hormones in male epileptic patients receiving anticonvulsant medication. Arch Nnirril, 1990; 47:670-676.
- Johannarattya R. The effect of anticonvulsant on growth and sexual maturation in girls with epilepsy. Pediatrics, 1999; 103:588-593.
- Berent S. Modern approaches to neuropsychological testing. Ailv Neural, 1991; 55:423-437.
- Connacher AA, Borsey DQ. The effective evaluation of thyroid status in patients on phenytoin, carbamazepine or sodium valproate attending as epilepsy clinic. Pediatrics international 2007; 49(6):822-826.
- Surks MI. Normal serum free thyroid hormone concentration in patients treated with anticonvulsant drugs. A paradox resolved JAMA, 1996; 275:1495-1498.
- Rootwelt K. Effect of anticonvulsant drugs on serum levels on thyroid hormones and thyrotropin in human. Scanu J Clin lab Invst, 1978; 38:731-736.
- Kazuhiro T, Soichi K. Thyroid function in children with long term anticonvulsant treatment. Pediatr Neuroscience, 1987; 13:90-94.
- Attilako A, Katsarou E. Thyroid function in children with epilepsy treated with sodium valproate monotherapy. Clin Neuropharmacol, 2009; 32(1):32-34.
- Achilleas A. Anastasia G. Thyroid function in epileptic patients treated with sodium valproate mono therapy. Postgrad Med J 1987; 63:841-845.
- Vainionpaa LK. Thyroid function in girls with epilepsy with anticonvulsant drugs and after withdrawal of medications. Epilepsia, 2004; 45(3):197-203.
- Díez JJ, Iglesias P: Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab 2004; 89:4890– 4897.
- Eiris-Punal J, Del Rio-Garma M, Del Rio-Garma MC, et al: Long-term treatment of Children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism. Epilepsia 1999; 40:1761–1766.
- Vainionpaa LK, Mikkonen K, Rattya J, et al: Thyroid function in girls with epilepsy with Carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication. Epilepsia 2004; 45:197–203.
- Isojarvi JI, Pakarinen AJ, Myllyla VV: Thyroid function with antiepileptic drugs. Epilepsia 1992; 33:142–148.